Abstract
Bruceantin (1), a classical quassinoid with the highest reported antimalarial activity among the quassinoids examined thus far, was selected as a natural product lead for the design of a series of A/B-ring analogs. A viable strategy for the synthesis of the series was developed. The functionalized A-ring and the C-15 ester moiety in bruceantin are incorporated in all designed compounds. The preliminary bioassay results will be discussed in detail.
Keywords: bruceantin, partial analogs, bioassay, structure activity relationships, antileukemic and antimalarial activities
Medicinal Chemistry
Title: Synthesis of A/B-Ring Partial Analogs of Bruceantin as Potential Antimalarial Agents
Volume: 1 Issue: 1
Author(s): Z. Guo, S. Vangapandu, A. Nimrod, L. A. Walker and R. D. Sindelar
Affiliation:
Keywords: bruceantin, partial analogs, bioassay, structure activity relationships, antileukemic and antimalarial activities
Abstract: Bruceantin (1), a classical quassinoid with the highest reported antimalarial activity among the quassinoids examined thus far, was selected as a natural product lead for the design of a series of A/B-ring analogs. A viable strategy for the synthesis of the series was developed. The functionalized A-ring and the C-15 ester moiety in bruceantin are incorporated in all designed compounds. The preliminary bioassay results will be discussed in detail.
Export Options
About this article
Cite this article as:
Guo Z., Vangapandu S., Nimrod A., Walker A. L. and Sindelar D. R., Synthesis of A/B-Ring Partial Analogs of Bruceantin as Potential Antimalarial Agents, Medicinal Chemistry 2005; 1 (1) . https://dx.doi.org/10.2174/1573406053402488
DOI https://dx.doi.org/10.2174/1573406053402488 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vitamin D and miRNAs in Cancer
Current Gene Therapy Two Branched Polar Groups and Polar Linker Moieties of Thiophene Amide Derivatives Are Essential for MRP2/ABCC2 Recognition
Drug Metabolism Letters Role of Diet and Nutrition on the Alteration of the Quality and Quantity of Stem Cells in Human Aging and the Diseases of Aging
Current Pharmaceutical Design NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression
Anti-Cancer Agents in Medicinal Chemistry Use of Etanercept in the Treatment of Psoriasis and Psoriatic Arthritis
Reviews on Recent Clinical Trials Pharmacological Approaches of Alzheimer's Disease: An Update
Current Drug Therapy The PIK3CA Gene as a Mutated Target for Cancer Therapy
Current Cancer Drug Targets Development of New Fibrinolytic Agents
Current Pharmaceutical Design A Steroidal Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitor Triggers Pro-apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells
Anti-Cancer Agents in Medicinal Chemistry Synthesis of Six Phenylalanine Derivatives and their Cell Toxicity Effect on Human Colon Cancer Cell Line HT-29
Letters in Drug Design & Discovery Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)
Current Topics in Medicinal Chemistry Primary Sjogren’s Syndrome and the Type I Interferon System
Current Pharmaceutical Biotechnology Role of TGF- β in the Tumor Stroma
Current Cancer Drug Targets Therapeutic Targeting of Melanoma Cells Using Neural Stem Cells Expressing Carboxylesterase, a CPT-11 Activating Enzyme
Current Stem Cell Research & Therapy Application of Serial Analysis of Gene Expression in Cancer Research
Current Pharmaceutical Biotechnology Current Non-viral siRNA Delivery Systems as a Promising Treatment of Skin Diseases
Current Pharmaceutical Design Targeting Ion Channels for New Strategies in Cancer Diagnosis and Therapy
Current Clinical Pharmacology VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design Immunotherapy for Alzheimers Disease: Rational Basis in Ongoing Clinical Trials
Current Pharmaceutical Design Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry